Differential sensitivities of recombinant human topoisomerase IIalpha and beta to various classes of topoisomerase II-interacting agents (Q77379571)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Differential sensitivities of recombinant human topoisomerase IIalpha and beta to various classes of topoisomerase II-interacting agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

D Perrin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B van Hille

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B T Hill

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

503-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900082-3

10.1016/S0006-2952(98)00082-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9763227%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference